Multifunctional SAHA-derived 8-hydroxyquinoline metallopharmacophores: HDAC inhibition and antiproliferative activity
Inorganic Chemistry Frontiers · 2026 · 13 (14) · 6059-6068
DOI: 10.1039/d6qi00422a ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry Frontiers, 2026. Verfasst von Chen Chen und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: China Scholarship Council, University of Auckland, Grantová Agentura České Republiky.
Abstract (Originalsprache)
Conjugation of SAHA (vorinostat), a clinically used pan-HDAC inhibitor, to organometallic scaffolds based on 8-hydoxyquinoline gave potent anticancer agents. The nature of the ligand determined the HDAC inhibitory activity of the compounds.
Förderung
- China Scholarship Council
- University of Auckland
- Grantová Agentura České Republiky
Zitieren
APA
Chen, C., Havlínová, B., Vošahlíková, M., Tučková, R., Stjärnhage, J., Lin, Z., Rayner, C., Bařinka, C., Söhnel, T., Jamieson, S. M. F., & Hartinger, C. G. (2026). Multifunctional SAHA-derived 8-hydroxyquinoline metallopharmacophores: HDAC inhibition and antiproliferative activity. Inorganic Chemistry Frontiers, 13(14), 6059-6068. https://doi.org/10.1039/d6qi00422a
Vancouver
Chen C, Havlínová B, Vošahlíková M, Tučková R, Stjärnhage J, Lin Z, et al. Multifunctional SAHA-derived 8-hydroxyquinoline metallopharmacophores: HDAC inhibition and antiproliferative activity. Inorganic Chemistry Frontiers. 2026;13(14):6059-6068. doi:10.1039/d6qi00422a
BibTeX
@article{Chen2026,
author = {Chen, Chen and Havlínová, Barbora and Vošahlíková, Miroslava and Tučková, Růžena and Stjärnhage, Julia and Lin, Zexiong and Rayner, Charlotte and Bařinka, Cyril and Söhnel, Tilo and Jamieson, Stephen M. F. and Hartinger, Christian G.},
title = {Multifunctional SAHA-derived 8-hydroxyquinoline metallopharmacophores: HDAC inhibition and antiproliferative activity},
journal = {Inorganic Chemistry Frontiers},
year = {2026},
volume = {13},
number = {14},
pages = {6059--6068},
doi = {10.1039/d6qi00422a}
}
EUVIMED